SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000891092-00-000849
Filing Date
2000-09-22
Accepted
2000-09-22 00:00:00
Documents
1
Group Members
CADUCEUS CAPITAL TRUSTCADUCEUS CAPTITAL II, L.P.EATON VANCE WORLDWIDE HEALTH SCIENCES FUNDFINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLCORBIMED ADVISERS INC /CTORBIMED ADVISORS LLCPAINEWEBBER EUCALYPTUS FUND, LLCPAINEWEBBER EUCALYPTUS FUND, LTD.PHARMA/WHEALT

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 0001.txt SC 13G 19728
  Complete submission text file 0000891092-00-000849.txt   22289
Mailing Address 70 WOOD AVENUE SOUTH ISELIN NJ 08830
Business Address 70 WOOD AVE S ISELIN NJ 08830 9086328800
BIO TECHNOLOGY GENERAL CORP (Subject) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-34455 | Film No.: 727157
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)